Clinical Trial Update: Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial in extensive-stage small cell lung cancer comparing sequential Benmelstobart with Anlotinib to sequential Tislelizumab following standard chemothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: RECRUITING